Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 06 2023 - 8:30AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, today announced that Paul
Bolno, MD, MBA, President and Chief Executive Officer, is scheduled
to participate in a virtual analyst-led fireside chat at the H.C.
Wainwright 25th Annual Global Investment Conference. The
presentation will be available to view beginning on Monday,
September 11, 2023, at 7:00 a.m. ET.
A live webcast of this presentation will be available on the
Investor Relations page of the Wave Life Sciences website at
http://ir.wavelifesciences.com. Replay of this presentation will be
archived and available on the site for a limited time following the
event.
About Wave Life SciencesWave Life Sciences
(Nasdaq: WVE) is a clinical-stage RNA medicines company committed
to delivering life-changing treatments for people battling
devastating diseases. Wave aspires to develop best-in-class
medicines across multiple therapeutic modalities using PRISM, the
company’s proprietary discovery and drug development platform that
enables the precise design, optimization, and production of
stereopure oligonucleotides. Driven by a resolute sense of urgency,
the Wave team is targeting a broad range of genetically defined
diseases so that patients and families may realize a brighter
future. To find out more, please
visit www.wavelifesciences.com and follow Wave on
Twitter @WaveLifeSci.
Investor Contact:Kate Rausch+1
617-949-4827krausch@wavelifesci.com
Media Contact:Alicia Suter+1
617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2024 to May 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From May 2023 to May 2024